findmyKOL
Clinical trialNCT00154102CompletedPhase 3Interventional

Cetuximab Combined With Irinotecan in First-line Therapy for Metastatic Colorectal Cancer (CRYSTAL)

SponsorMerck KGaA, Darmstadt, GermanyEnrollment1,221Epidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

154 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Research Site

    Buenos Aires, Argentina

Australia
  • Research Site

    Bedford Park, Australia

  • Research Site

    Darlinghurst, Australia

  • Research Site

    Heidelberg, Australia

  • Research Site

    Nedlands, Australia

  • Research Site

    West Perth, Australia

  • Research Site

    Woodville, Australia

Austria
  • Research Site

    Innsbruck, Austria

  • Research Site

    Klagenfurt, Austria

  • Research Site

    Kufstein, Austria

  • Research Site

    Salzburg, Austria

  • Research Site

    Sankt Pölten, Austria

  • Research Site

    Sankt Veit an der Glan, Austria

  • Research Site

    Vienna, Austria

  • Research Site

    Wels, Austria

Belgium
  • Research Site

    Antwerp, Belgium

  • Research Site

    Bonheiden, Belgium

  • Research Site

    Brussels, Belgium

  • Research Site

    Edegem, Belgium

  • Research Site

    Ghent, Belgium

  • Research Site

    Leuven, Belgium

  • Research Site

    Liège, Belgium

Brazil
  • Research Site

    Goiânia, Brazil

  • Research Site

    Porto Alegre, Brazil

  • Research Site

    Santo André, Brazil

  • Research Site

    São Paulo, Brazil

Bulgaria
  • Research Site

    Pleven, Bulgaria

  • Research Site

    Plovidiv, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Varna, Bulgaria

Chile
  • Research Site

    Santiago-Las Condes, Chile

  • Research Site

    Santiago-Providencia, Chile

Czechia
  • Research Site

    Chomutov, Czechia

  • Research Site

    Prague, Czechia

Finland
  • Research Site

    Turku, Finland

France
  • Research Site

    Bordeaux, France

  • Research Site

    Boulogne-Billancourt, France

  • Research Site

    Colmar, France

  • Research Site

    Grenoble, France

  • Research Site

    La Roche-sur-Yon, France

114 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cetuximab →FOLFIRI Regimen →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2004
Primary completion
31 Dec 2006
Completion
31 Mar 2011
Last update posted
30 Jan 2017
Registered enrollment
1,221
Registry id
NCT00154102
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.